Trial Profile
Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms OCT-DES
- 06 Aug 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 12 Mar 2014 New trial record